Completed PHASE4 INTERVENTIONAL 2-arm NCT01644721

Trial of Additional Measles Vaccine to Reduce Child Mortality

A Two-site Randomised Trial of an Additional Measles Vaccine at 4 Months of Age to Reduce Child Mortality in Rural Areas of Burkina Faso and Guinea-Bissau

Sponsor: Bandim Health Project

Conditions Measles Vaccine

Interventions Early measles vaccine

Updated 6 times since 2017 Last updated: Feb 9, 2026 Started: Jul 31, 2012 Primary completion: Jun 30, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Measles Vaccine, this trial is completed. The trial is conducted by Bandim Health Project and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Completed PHASE4

Status: Unknown → Completed
Sep 2024 — Feb 2026 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bandim Health Project
Centre de Recherche en Sante de Nouna, Burkina Faso
Heidelberg University
National Institute for Public Health and the Environment, RIVM, Holland
Navrongo Health Research Centre, Ghana

Data source: Bandim Health Project

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bissau, Guinea-Bissau